News

Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...
A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...
A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...
Techland has officially confirmed the release date for Dying Light: The Beast: August 22, 2025. Fans of the franchise can ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its ...
EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...
If you're looking for a game that is dangerously addictive, check out these 11 Best Games With 'One More Day' Gameplay Loops ...
A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...
Novocure's PANOVA-3 trial shows that the TTFields combo boosts survival in pancreatic cancer, hitting the primary endpoint.
Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...